Notably, TRPV6 is overexpressed in some of the most aggressive human cancers, including leukemia, as well as breast, prostate, colon, ovarian, thyroid, and endometrial cancers27–31, and its overexpression correlates with disease severity32,33. Here, TRPV6 is linked to cancer.